HEADER INHIBITOR 06-JAN-09 2W7Z TITLE STRUCTURE OF THE PENTAPEPTIDE REPEAT PROTEIN EFSQNR, A DNA TITLE 2 GYRASE INHIBITOR. FREE AMINES MODIFIED BY CYCLIC TITLE 3 PENTYLATION WITH GLUTARALDEHYDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENTAPEPTIDE REPEAT FAMILY PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EFSQNR; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: CHEMICAL MODIFICATION OF THE FREE AMINES ( LYSINES, COMPND 7 N-TERMINUS) BY TREATMENT WITH GLUTARALDEHYDE UNDER REDUCING COMPND 8 CONDITIONS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS; SOURCE 3 ORGANISM_TAXID: 1351; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS GLUTARALDEHYDE, GYRASE INHIBITOR, CYCLIC PENTYLATION, CHEMICAL KEYWDS 2 MODIFICATION, PENTAPEPTIDE REPEAT PROTEIN, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR M.W.VETTING,S.S.HEGDE,J.S.BLANCHARD REVDAT 2 13-JUL-11 2W7Z 1 VERSN REVDAT 1 05-MAY-09 2W7Z 0 JRNL AUTH M.W.VETTING,S.S.HEGDE,J.S.BLANCHARD JRNL TITL CRYSTALLIZATION OF A PENTAPEPTIDE-REPEAT PROTEIN BY JRNL TITL 2 REDUCTIVE CYCLIC PENTYLATION OF FREE AMINES WITH JRNL TITL 3 GLUTARALDEHYDE. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 65 462 2009 JRNL REFN ISSN 0907-4449 JRNL PMID 19390151 JRNL DOI 10.1107/S0907444909008324 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 51172 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2736 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3093 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3670 REMARK 3 BIN FREE R VALUE SET COUNT : 193 REMARK 3 BIN FREE R VALUE : 0.4460 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3489 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 417 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.05000 REMARK 3 B22 (A**2) : 0.63000 REMARK 3 B33 (A**2) : -0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.105 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.102 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.462 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3592 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4894 ; 1.404 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 426 ; 5.894 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 188 ;38.412 ;24.787 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 511 ;10.746 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;15.218 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 531 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2756 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1643 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2495 ; 0.317 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 285 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 47 ; 0.166 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 31 ; 0.172 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2172 ; 0.715 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3430 ; 1.093 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1594 ; 2.030 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1464 ; 3.140 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 114 REMARK 3 ORIGIN FOR THE GROUP (A): 22.4110 4.3140 74.2590 REMARK 3 T TENSOR REMARK 3 T11: 0.0161 T22: 0.0174 REMARK 3 T33: 0.0087 T12: 0.0386 REMARK 3 T13: -0.0168 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 0.9280 L22: 0.5834 REMARK 3 L33: 1.9908 L12: 0.2595 REMARK 3 L13: 0.4363 L23: 0.2256 REMARK 3 S TENSOR REMARK 3 S11: 0.0008 S12: 0.0298 S13: -0.0387 REMARK 3 S21: 0.0797 S22: 0.0099 S23: -0.0707 REMARK 3 S31: 0.0731 S32: 0.0532 S33: -0.0108 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 115 A 168 REMARK 3 ORIGIN FOR THE GROUP (A): 12.5560 0.7690 59.4350 REMARK 3 T TENSOR REMARK 3 T11: 0.0308 T22: 0.0573 REMARK 3 T33: 0.0201 T12: 0.0229 REMARK 3 T13: -0.0020 T23: -0.0177 REMARK 3 L TENSOR REMARK 3 L11: 1.5491 L22: 1.2640 REMARK 3 L33: 2.2674 L12: 0.1410 REMARK 3 L13: 0.7798 L23: 0.4229 REMARK 3 S TENSOR REMARK 3 S11: 0.0422 S12: 0.0750 S13: -0.0746 REMARK 3 S21: -0.0336 S22: -0.0297 S23: -0.0014 REMARK 3 S31: 0.1270 S32: -0.0584 S33: -0.0125 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 169 A 211 REMARK 3 ORIGIN FOR THE GROUP (A): 5.3910 -3.8820 47.0410 REMARK 3 T TENSOR REMARK 3 T11: 0.0107 T22: 0.0787 REMARK 3 T33: -0.0042 T12: 0.0154 REMARK 3 T13: -0.0061 T23: -0.0404 REMARK 3 L TENSOR REMARK 3 L11: 1.3880 L22: 0.8015 REMARK 3 L33: 3.0839 L12: 0.9163 REMARK 3 L13: 1.6316 L23: 0.9819 REMARK 3 S TENSOR REMARK 3 S11: 0.0255 S12: 0.1294 S13: -0.0266 REMARK 3 S21: -0.0483 S22: 0.0069 S23: -0.0493 REMARK 3 S31: 0.0779 S32: 0.0232 S33: -0.0324 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 4 B 109 REMARK 3 ORIGIN FOR THE GROUP (A): -21.3320 -0.3630 6.9230 REMARK 3 T TENSOR REMARK 3 T11: 0.1194 T22: -0.0408 REMARK 3 T33: 0.0028 T12: -0.0350 REMARK 3 T13: -0.0320 T23: 0.0289 REMARK 3 L TENSOR REMARK 3 L11: 1.0133 L22: 1.7928 REMARK 3 L33: 1.8804 L12: 0.0304 REMARK 3 L13: 0.0495 L23: 0.4331 REMARK 3 S TENSOR REMARK 3 S11: -0.0281 S12: -0.0092 S13: 0.0517 REMARK 3 S21: -0.4345 S22: 0.0655 S23: 0.2231 REMARK 3 S31: -0.3038 S32: -0.0039 S33: -0.0375 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 110 B 180 REMARK 3 ORIGIN FOR THE GROUP (A): -11.1220 -2.1970 23.6120 REMARK 3 T TENSOR REMARK 3 T11: 0.0240 T22: 0.0572 REMARK 3 T33: 0.0210 T12: -0.0270 REMARK 3 T13: 0.0387 T23: -0.0098 REMARK 3 L TENSOR REMARK 3 L11: 0.9274 L22: 1.5370 REMARK 3 L33: 1.9092 L12: 0.1307 REMARK 3 L13: 0.6188 L23: 0.3462 REMARK 3 S TENSOR REMARK 3 S11: -0.0107 S12: -0.0887 S13: 0.0120 REMARK 3 S21: -0.0257 S22: 0.1090 S23: -0.0334 REMARK 3 S31: -0.1503 S32: 0.0975 S33: -0.0983 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 181 B 211 REMARK 3 ORIGIN FOR THE GROUP (A): 0.1720 -3.4960 35.4250 REMARK 3 T TENSOR REMARK 3 T11: 0.0156 T22: 0.1065 REMARK 3 T33: 0.0182 T12: 0.0046 REMARK 3 T13: -0.0013 T23: -0.0612 REMARK 3 L TENSOR REMARK 3 L11: 1.0759 L22: 0.1670 REMARK 3 L33: 2.2725 L12: -0.0341 REMARK 3 L13: 0.5165 L23: -0.5269 REMARK 3 S TENSOR REMARK 3 S11: 0.0630 S12: -0.0707 S13: 0.0652 REMARK 3 S21: 0.1040 S22: 0.0071 S23: -0.0116 REMARK 3 S31: 0.0221 S32: 0.1284 S33: -0.0702 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. PROTEIN WAS PRODUCED WITH N-TERMINAL REMARK 3 THROMBIN CLEAVABLE TAG. PROTEIN WAS CRYSTALLIZED AFTER REMARK 3 THROMBIN CLEAVAGE, LEAVING A NON-NATIVE N-TERMINUS OF REMARK 3 GLYSERHIS-MET1 REMARK 4 REMARK 4 2W7Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JAN-09. REMARK 100 THE PDBE ID CODE IS EBI-38496. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU-H3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : R-AXIS IV REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53909 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.60 REMARK 200 RESOLUTION RANGE LOW (A) : 20.60 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 2.9 REMARK 200 R MERGE (I) : 0.04 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.7 REMARK 200 R MERGE FOR SHELL (I) : 0.25 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN - 10 MG/ML, 400 MM REMARK 280 AMMONIUM SULFATE, 15 MM HEPES PH 7.5, 1 MM DTT, 1 MM ETDA REMARK 280 PRECIPITANT - 100 MM MES PH 6.5, 5-15% PEG 6000, 1M LICL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.56950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 PRO A 9 REMARK 465 ASN A 10 REMARK 465 LEU A 11 REMARK 465 PRO A 12 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 LP6 B 2 REMARK 465 ILE B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2035 O HOH B 2078 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 81 19.70 58.36 REMARK 500 TRP A 84 54.97 -117.79 REMARK 500 LEU A 131 83.95 69.68 REMARK 500 TRP B 84 53.67 -118.32 REMARK 500 LEU B 131 73.64 66.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 LYSYL-PIPERIDINE (LPD): UNSATURATED SIX-MEMBERED RING, WITH REMARK 600 PROTONATED NITROGEN, SP3 GEOMETRY, AND FIVE CARBONS, A REMARK 600 PIPERIDINE GROUP ON LYSINE SIDE CHAIN. REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1213 DBREF 2W7Z A -2 0 PDB 2W7Z 2W7Z -2 0 DBREF 2W7Z A 1 211 UNP Q837D8 Q837D8_ENTFA 1 211 DBREF 2W7Z B -2 0 PDB 2W7Z 2W7Z -2 0 DBREF 2W7Z B 1 211 UNP Q837D8 Q837D8_ENTFA 1 211 SEQRES 1 A 214 GLY SER HIS MET LP6 ILE THR TYR PRO LEU PRO PRO ASN SEQRES 2 A 214 LEU PRO GLU GLN LEU PRO LEU LEU THR ASN CYS GLN LEU SEQRES 3 A 214 GLU ASP GLU ALA ILE LEU GLU ASN HIS LEU TYR GLN GLN SEQRES 4 A 214 ILE ASP LEU PRO ASN GLN GLU VAL ARG ASN LEU VAL PHE SEQRES 5 A 214 ARG ASP ALA VAL PHE ASP HIS LEU SER LEU ALA ASN GLY SEQRES 6 A 214 GLN PHE ALA SER PHE ASP CYS SER ASN VAL ARG PHE GLU SEQRES 7 A 214 ALA CYS ASP PHE SER ASN VAL GLU TRP LEU SER GLY SER SEQRES 8 A 214 PHE HIS ARG VAL THR PHE LEU ARG CYS ASN LEU THR GLY SEQRES 9 A 214 THR ASN PHE ALA ASP SER TYR LEU LP6 ASP CYS LEU PHE SEQRES 10 A 214 GLU ASP CYS LP6 ALA ASP TYR ALA SER PHE ARG PHE ALA SEQRES 11 A 214 ASN PHE ASN LEU VAL HIS PHE ASN GLN THR ARG LEU VAL SEQRES 12 A 214 GLU SER GLU PHE PHE GLU VAL THR TRP LP6 LP6 LEU LEU SEQRES 13 A 214 LEU GLU ALA CYS ASP LEU THR GLU SER ASN TRP LEU ASN SEQRES 14 A 214 THR SER LEU LP6 GLY LEU ASP PHE SER GLN ASN THR PHE SEQRES 15 A 214 GLU ARG LEU THR PHE SER PRO ASN TYR LEU SER GLY LEU SEQRES 16 A 214 LP6 VAL THR PRO GLU GLN ALA ILE TYR LEU ALA SER ALA SEQRES 17 A 214 LEU GLY LEU VAL ILE THR SEQRES 1 B 214 GLY SER HIS MET LP6 ILE THR TYR PRO LEU PRO PRO ASN SEQRES 2 B 214 LEU PRO GLU GLN LEU PRO LEU LEU THR ASN CYS GLN LEU SEQRES 3 B 214 GLU ASP GLU ALA ILE LEU GLU ASN HIS LEU TYR GLN GLN SEQRES 4 B 214 ILE ASP LEU PRO ASN GLN GLU VAL ARG ASN LEU VAL PHE SEQRES 5 B 214 ARG ASP ALA VAL PHE ASP HIS LEU SER LEU ALA ASN GLY SEQRES 6 B 214 GLN PHE ALA SER PHE ASP CYS SER ASN VAL ARG PHE GLU SEQRES 7 B 214 ALA CYS ASP PHE SER ASN VAL GLU TRP LEU SER GLY SER SEQRES 8 B 214 PHE HIS ARG VAL THR PHE LEU ARG CYS ASN LEU THR GLY SEQRES 9 B 214 THR ASN PHE ALA ASP SER TYR LEU LP6 ASP CYS LEU PHE SEQRES 10 B 214 GLU ASP CYS LP6 ALA ASP TYR ALA SER PHE ARG PHE ALA SEQRES 11 B 214 ASN PHE ASN LEU VAL HIS PHE ASN GLN THR ARG LEU VAL SEQRES 12 B 214 GLU SER GLU PHE PHE GLU VAL THR TRP LP6 LP6 LEU LEU SEQRES 13 B 214 LEU GLU ALA CYS ASP LEU THR GLU SER ASN TRP LEU ASN SEQRES 14 B 214 THR SER LEU LP6 GLY LEU ASP PHE SER GLN ASN THR PHE SEQRES 15 B 214 GLU ARG LEU THR PHE SER PRO ASN TYR LEU SER GLY LEU SEQRES 16 B 214 LP6 VAL THR PRO GLU GLN ALA ILE TYR LEU ALA SER ALA SEQRES 17 B 214 LEU GLY LEU VAL ILE THR MODRES 2W7Z LP6 A 2 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 110 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 118 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 150 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 151 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 170 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 A 193 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 110 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 118 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 150 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 151 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 170 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE MODRES 2W7Z LP6 B 193 LYS 6-PIPERIDIN-1-YL-L-NORLEUCINE HET LP6 A 2 14 HET LP6 A 110 14 HET LP6 A 118 14 HET LP6 A 150 14 HET LP6 A 151 14 HET LP6 A 170 14 HET LP6 A 193 14 HET LP6 B 110 14 HET LP6 B 118 14 HET LP6 B 150 14 HET LP6 B 151 14 HET LP6 B 170 14 HET LP6 B 193 14 HET CL B1212 1 HET CL B1213 1 HET CL A1212 1 HET CL A1213 1 HETNAM CL CHLORIDE ION HETNAM LP6 6-PIPERIDIN-1-YL-L-NORLEUCINE FORMUL 3 CL 4(CL 1-) FORMUL 4 LP6 13(C11 H22 N2 O2) FORMUL 5 HOH *417(H2 O) HELIX 1 1 SER A 185 LEU A 189 5 5 HELIX 2 2 THR A 195 LEU A 206 1 12 HELIX 3 3 PRO B 186 LEU B 189 5 4 HELIX 4 4 THR B 195 LEU B 206 1 12 SHEET 1 AA 4 LEU A 17 LEU A 18 0 SHEET 2 AA 4 LEU A 33 ASP A 38 1 O LEU A 33 N LEU A 18 SHEET 3 AA 4 VAL A 48 SER A 58 1 O VAL A 53 N TYR A 34 SHEET 4 AA 4 ILE A 28 GLU A 30 1 O LEU A 29 N ARG A 50 SHEET 1 AB 8 LEU A 17 LEU A 18 0 SHEET 2 AB 8 LEU A 33 ASP A 38 1 O LEU A 33 N LEU A 18 SHEET 3 AB 8 VAL A 48 SER A 58 1 O VAL A 53 N TYR A 34 SHEET 4 AB 8 ASP A 68 GLU A 75 1 O ASP A 68 N PHE A 49 SHEET 5 AB 8 SER A 88 LEU A 95 1 O SER A 88 N CYS A 69 SHEET 6 AB 8 TYR A 108 GLU A 115 1 O TYR A 108 N PHE A 89 SHEET 7 AB 8 ASN A 128 ASN A 135 1 O ASN A 128 N LEU A 109 SHEET 8 AB 8 LEU A 153 GLU A 155 1 O LEU A 153 N PHE A 134 SHEET 1 AC 2 GLU A 43 ARG A 45 0 SHEET 2 AC 2 GLN A 63 ALA A 65 1 O GLN A 63 N VAL A 44 SHEET 1 BA 4 LEU B 17 LEU B 18 0 SHEET 2 BA 4 LEU B 33 ASP B 38 1 O LEU B 33 N LEU B 18 SHEET 3 BA 4 VAL B 48 SER B 58 1 O VAL B 53 N TYR B 34 SHEET 4 BA 4 ILE B 28 GLU B 30 1 O LEU B 29 N ARG B 50 SHEET 1 BB 8 LEU B 17 LEU B 18 0 SHEET 2 BB 8 LEU B 33 ASP B 38 1 O LEU B 33 N LEU B 18 SHEET 3 BB 8 VAL B 48 SER B 58 1 O VAL B 53 N TYR B 34 SHEET 4 BB 8 ASP B 68 GLU B 75 1 O ASP B 68 N PHE B 49 SHEET 5 BB 8 SER B 88 LEU B 95 1 O SER B 88 N CYS B 69 SHEET 6 BB 8 TYR B 108 GLU B 115 1 O TYR B 108 N PHE B 89 SHEET 7 BB 8 ASN B 128 ASN B 135 1 O ASN B 128 N LEU B 109 SHEET 8 BB 8 LEU B 153 GLU B 155 1 O LEU B 153 N PHE B 134 SHEET 1 BC 2 SER B 162 TRP B 164 0 SHEET 2 BC 2 LEU B 182 PHE B 184 1 O THR B 183 N TRP B 164 LINK C MET A 1 N LP6 A 2 1555 1555 1.33 LINK C LP6 A 2 N ILE A 3 1555 1555 1.33 LINK C LEU A 109 N LP6 A 110 1555 1555 1.33 LINK C LP6 A 110 N ASP A 111 1555 1555 1.34 LINK C CYS A 117 N LP6 A 118 1555 1555 1.33 LINK C LP6 A 118 N ALA A 119 1555 1555 1.33 LINK C TRP A 149 N LP6 A 150 1555 1555 1.34 LINK C LP6 A 150 N LP6 A 151 1555 1555 1.33 LINK C LP6 A 151 N LEU A 152 1555 1555 1.33 LINK C LEU A 169 N LP6 A 170 1555 1555 1.33 LINK C LP6 A 170 N GLY A 171 1555 1555 1.33 LINK C LEU A 192 N LP6 A 193 1555 1555 1.33 LINK C LP6 A 193 N VAL A 194 1555 1555 1.33 LINK C LEU B 109 N LP6 B 110 1555 1555 1.33 LINK C LP6 B 110 N ASP B 111 1555 1555 1.34 LINK C CYS B 117 N LP6 B 118 1555 1555 1.33 LINK C LP6 B 118 N ALA B 119 1555 1555 1.33 LINK C TRP B 149 N LP6 B 150 1555 1555 1.32 LINK C LP6 B 150 N LP6 B 151 1555 1555 1.33 LINK C LP6 B 151 N LEU B 152 1555 1555 1.33 LINK C LEU B 169 N LP6 B 170 1555 1555 1.34 LINK C LP6 B 170 N GLY B 171 1555 1555 1.33 LINK C LEU B 192 N LP6 B 193 1555 1555 1.34 LINK C LP6 B 193 N VAL B 194 1555 1555 1.33 SITE 1 AC1 2 ARG B 73 THR B 93 SITE 1 AC2 3 THR B 178 PHE B 179 GLN B 198 SITE 1 AC3 2 SER A 185 ASN A 187 SITE 1 AC4 4 LEU A 154 ASP A 173 GLN A 176 HOH A2169 CRYST1 36.930 63.139 94.619 90.00 96.09 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027078 0.000000 0.002889 0.00000 SCALE2 0.000000 0.015838 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010629 0.00000 MTRIX1 1 -0.850900 -0.523700 -0.040450 2.74100 1 MTRIX2 1 -0.520600 0.830600 0.197600 -7.34700 1 MTRIX3 1 -0.069880 0.189200 -0.979500 81.33000 1